Franklin Berger

Part of Imagyn Medical Technologies, Inc., Microsurge, Inc. is a company that manufactures medical devices. The company is based in Needham, MA. The company was founded by E. James Hutchens. Microsurge was acquired by Urohealth Systems, Inc. on March 13, 1997 for $29 million.

Ellipse Technologies, Inc. develops and commercializes implants for spinal and orthopedic applications. It designs, develop and commercialize non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. The company was founded by Samuel M. Shaolian and Shawn Moaddeb on June 30, 2005 and is headquartered in Aliso Viejo, CA.

ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. The company also develops Raindrop Near Vision Corneal Inlay, which is a refractive surgery solution. ReVision Optics was founded by Hansen A. Yuan, Adrian Koppes and Alok Nigam in 1996 and is headquartered Lake Forest, CA.

Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA.

Cerebrotech Medical Systems, Inc. develops a technology for non-invasive monitor for early detection of cerebral events that can be catastrophic for patients after stroke, traumatic brain injury, brain surgery and other conditions. The company was founded by Mitchell E. Levinson in 2010 and is headquartered in Pleasanton, CA.

Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom.

Embrella Cardiovascular, Inc. develops proprietary systems for embolic cerebral protection during cardiovascular procedures. The company was founded by Judith T. Carpenter and Jeffrey Francis O'Donnell, Sr. in 2007 and is headquartered in Wayne, PA.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin.